HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology

Go back to HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.39 -0.02 (4.88%)
Previous Close $0.41    52 Week High $21.68 
Open $0.41    52 Week Low $8.74 
Day High $0.41    P/E N/A 
Day Low $0.39    EPS $-0.46 
Volume 385,682